Opioid utilization and opioid-related adverse events in nonsurgical patients in US hospitals.
Opioid utilization and opioid-related adverse events in nonsurgical patients in US hospitals.
复制标题
DOI：
10.1002/jhm.2102
复制
发表时间：
2014-02
影响因子：
2.6
通讯作者：
Marcantonio, Edward R.
中科院分区：
文献类型：
--
作者：
Herzig, Shoshana J.;Rothberg, Michael B.;Cheung, Michael;Ngo, Long H.;Marcantonio, Edward R.
Recent studies in the outpatient setting have demonstrated high rates of opioid prescribing and overdose-related deaths. Prescribing practices in hospitalized patients are unexamined. To investigate patterns and predictors of opioid utilization in non-surgical admissions to U.S. hospitals, variation in use, and the association between hospital-level use and rates of severe opioid-related adverse events. Adult non-surgical admissions to 286 U.S. hospitals. Opioid exposure and severe opioid-related adverse events during hospitalization, defined using hospital charges and ICD-9-CM codes. Of 1.14 million admissions, opioids were used in 51%. The mean ± s.d. daily dose received in oral morphine equivalents (OME) was 68 ± 185 mg; 23% of exposed received a total daily dose of ≥ 100 mg OME. Opioid prescribing rates ranged from 5% in the lowest to 72% in the highest prescribing hospital (mean 51% ± 10%). After adjusting for patient characteristics, the adjusted opioid prescribing rates ranged from 33–64% (mean 50% ± s.d. 4%). Among exposed, 0.97% experienced severe opioid-related adverse events. Hospitals with higher opioid prescribing rates had higher adjusted relative risk of a severe opioid-related adverse event per patient exposed (RR 1.23 [1.14–1.33] for highest compared to lowest prescribing quartile). The majority of hospitalized non-surgical patients were exposed to opioids, often at high doses. Hospitals that used opioids most frequently had increased adjusted risk of a severe opioid-related adverse event per patient exposed. Interventions to standardize and enhance the safety of opioid prescribing in hospitalized patients should be investigated.
登录
查看更多内容
影响因子：
2.9
作者：
Haupt, Martin;Cruz-Jentoft, Affionso;Jeste, Dilip
通讯作者：
Jeste, Dilip
影响因子：
3.7
作者：
Pronovost, P;Weast, B;Lipsett, P
通讯作者：
Lipsett, P
影响因子：
--
作者：
Rozich, JD;Haraden, CR;Resar, RK
通讯作者：
Resar, RK
影响因子：
39.2
作者：
Dunn, Kate M.;Saunders, Kathleen W.;Von Korff, Michael
通讯作者：
Von Korff, Michael
影响因子：
3
作者：
Elixhauser, A;Steiner, C;Coffey, RN
通讯作者：
Coffey, RN